| Literature DB >> 32352074 |
Mirella Facin1, Carlos Alberto Pastore1, Nelson Samesima1, Horacio Gomes Pereira Filho1.
Abstract
BACKGROUND: Primary cardiac tumours are rare in children. Against this backdrop, Doppler echocardiogram is the main diagnostic procedure, while electrocardiogram (ECG) usually plays a secondary role, by detecting tumoural consequences as cardiac arrhythmias and chambers overload. We describe a case where an electrocardiographic sign was the cornerstone to diagnosis and surveillance of an infant with a cardiac rhabdomyoma. CASEEntities:
Keywords: Cardiac tumours; Case report; Electrocardiogram; Rhabdomyoma; Tuberous sclerosis complex
Year: 2020 PMID: 32352074 PMCID: PMC7180701 DOI: 10.1093/ehjcr/ytaa025
Source DB: PubMed Journal: Eur Heart J Case Rep ISSN: 2514-2119
Results and reference values, according to age and sex, of the most relevant laboratorial tests performed in our patient
| Laboratorial examination | Results | Reference Value |
|---|---|---|
|
| 10.7 g/dL | 10.3–13.7 g/dL |
|
| 0.26 mg/dL | 0.17–0.42 mg/dL |
|
| 4.3 mEq/L | 3.5–5.0 mEq/L |
|
| 137 mEq/L | 135–145 mEq/L |
|
| 5.39 mg/dL | 4.8–5.5 mg/dL |
|
| 2.07 mg/dL | 1.71–2.29 mg/dL |
|
| 45 µmol/L | 21–50 µmol/L |
|
| 83 mg/dL | 60–110 mg/dL |
|
| 8.27 µIU/mL | 0.27–10 µIU/mL |
|
| 1.12 ng/dL | 0.93–1.70 ng/dL |
|
| 3.2 ng/mL | Until 3.8 ng/mL |
|
| <0.006 ng/mL | Until 0.04 ng/mL |
Revised clinical diagnostic criteria
| Tuberous sclerosis complex clinical diagnostic criteria | |
|---|---|
| Genetic diagnostic criteria | |
| Identification of either TSC1 or TSC2 pathogenic mutations in DNA—note that in 10–25% of patients with TSC, no pathogenic mutation is identified by conventional genetic testing. Hence, a normal result does not exclude TSC diagnosis. | |
| Clinical diagnostic criteria | |
| Major features | Minor features |
| 1. Hypomelanotic macules (≥3, at least 5 mm diameter) | 1. ‘Confetti’ skin lesions |
| 2. Angiofibromas (≥3) or fibrous cephalic plaque | 2. Dental enamel pits (≥3) |
| 3. Ungueal fibromas (≥2) | 3. Intraoral fibromas (≥2) |
| 4. Shagreen patch | 4. Retinal achromic patch |
| 5. Multiple retinal hamartomas | 5. Multiple renal cysts |
| 6. Cortical dysplasias | 6. Non-renal hamartomas |
| 7. Sub-ependymal nodules | |
| 8. Sub-ependymal giant cell astrocytoma | |
| 9. Cardiac rhabdomyoma | |
| 10. Lymphangioleiomyomatosis (LAM) | |
| 11. Angiomyolipomas (≥2) | |
Identification of either TSC1 or TSC2 pathogenic mutations in DNA—note that in 10–25% of patients with TSC, no pathogenic mutation is identified by conventional genetic testing. Hence, a normal result does not exclude TSC diagnosis.
Definite TSC diagnosis: two major features or one major feature with ≥2 minor features. Possible diagnosis: either one major feature or ≥2 minor features.
Includes tubers and cerebral white matter migration lines.
A combination of the two major clinical features, LAM and angiomyolipomas, without other features does not meet criteria for a definite diagnosis.
| Time | Events |
|---|---|
| 18 January 2017 | Epilepsy diagnosis |
| 30 March 2017 |
Single cardiac rhabdomyoma (CR) detection Confirmation of TSC clinical diagnosis |
| 19 June 2018 | Multiple bilateral renal cysts observation during investigation of recurrent urinary tract infections |
|
31 October 2018 19 September 2018 |
Brain magnetic resonance imaging unveils tubers, cerebral white matter radial migration lines and ependymal nodules CR is no longer detected on echocardiography and ECG normalizes |